BLADDER CANCER STAGE I, WITH CANCER IN SITU

This adverse event was reported 216 times

These drugs are most commonly taken by patients reporting BLADDER CANCER STAGE I, WITH CANCER IN SITU:

# Drug Count
0 RANITIDINE HYDROCHLORIDE 30
1 RANITIDINE 29
2 ASPIRIN 3
3 ASPIRIN 325 MG 3
4 ASPIRIN 81 MG 3
5 LENALIDOMIDE 2
6 RITUXIMAB 2
7 ACETAMINOPHEN 1
8 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1
9 ATENOLOL 1
See all common drugs associated with BLADDER CANCER STAGE I, WITH CANCER IN SITU

BLADDER CANCER STAGE I, WITH CANCER IN SITU is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 30 0.0006
1 RANITIDINE 29 0.0001
2 PIOGLITAZONE 1 0.0000
3 METFORMIN HCL 1 0.0000
4 DOXORUBICIN 1 0.0000
5 RITUXIMAB 2 0.0000
6 RAMIPRIL 1 0.0000
7 ATENOLOL 1 0.0000
8 BISOPROLOL FUMARATE 1 0.0000
9 DICLOFENAC SODIUM 1 0.0000
See all drugs enriched for association with BLADDER CANCER STAGE I, WITH CANCER IN SITU